Friday, November 27, 2020

Yellow metal trades flat, buy the dip for a target of 48,800


Gold was trading flat with a negative bias in Indian markets on November 27, tracking muted trend in the international spot prices. On the Multi-Commodity Exchange (MCX), December gold contracts were trading lower by 0.05 percent at Rs 48,492 per 10 gram at 0920 hours. December silver was trading 0.4 percent lower at Rs 59,608 per kg.

Investors can look at buying the dip towards Rs 48,400 for an upside target of Rs 48,800 per 10 gm, experts say.

Gold and silver ended flat the previous day as markets were closed in the US for Thanksgiving Day. December gold futures contract settled at $1805.50 per troy ounce with a minor loss while silver settled at $23.36 per troy ounce.

Domestic markets settled on a positive note. Both the metals found support at lower levels from the weakness in the dollar index. The dollar index was trading near the crucial support of 92 and if it closes below the mark on a weekly closing basis could further support prices of precious metals, experts say.

On MCX, gold has support at 48,330-48,200 and resistance at 48,680-48,800. Silver's support is at 59,500-59,200 and resistance at 60,300-60,800, he said.

Jain suggests buying gold on dips around 48,400 with a stop loss of 48,200 for the target of 48,800 levels.


More Information Visit

                    ⇩
For Quick Trial – 91091 93302
or mail us here:  info@moneyplantresearch.com


Stock market opening bell



top 10 advisory firms in indore


For Quick Trial – 91091-93302 ✔
or mail us here: info@moneyplantresearch.com
or visit https://www.moneyplantresearch.com

Tuesday, November 24, 2020

Gold slips on hopes for vaccine, smooth White House transition

      


Gold extended declines to a four-month trough on Tuesday as investors dived into riskier assets following drugmaker AstraZeneca's boost to the coronavirus vaccine race and a U.S. federal agency's White House transition approval for Joe Biden.

Spot gold fell 0.5% to $1,825.99 per ounce by 0545 GMT, having earlier slid to its lowest since July 21 at $1,820.45. It slumped as much as 2.2% on Monday.

U.S. gold futures were down 0.9% at $1,821.30.

"Investors are clearly rallying around the narrative of a vaccine-fuelled economic reopening, to the point they're willing to look past the economic realities and potential downside risks that may lie ahead," said FXTM market analyst Han Tan.

Asian equities rose after AstraZeneca said on Monday its COVID-19 vaccine could be up to 90% effective.

Buoying risk sentiment further, U.S. President-elect Biden received the presidential transition go-ahead from a federal agency on Monday. On Twitter, President Donald Trump said he was recommending that his team "do what needs to be done with regard to initial protocols".

"The fact that we have a smoother transition between President-elect Biden and Trump is just another reason to think that the recovery as it is currently playing out has one less risk to it," said IG Markets analyst Kyle Rodda.

More Information Visit

                    ⇩
For Quick Trial – 91091 93302
or mail us here:  info@moneyplantresearch.com


Stock market opening bell



top 10 advisory firms in indore


For Quick Trial – 91091-93302 ✔
or mail us here: info@moneyplantresearch.com
or visit https://www.moneyplantresearch.com

Monday, November 23, 2020

BEML shares gain 2% on Rs 501-crore order from Delhi Metro



BEML share price gained more than 2 percent in the morning trade on November 23 after the company won an order from the Delhi Metro Rail Corporation (DMRC).

The company received a variation order to contract 'MRS1' from DMRC, for additional 12 trainsets of six cars each (a total of 72 coaches) to operate on Line 2B and seven of Mumbai metro project. The order is valued at about Rs 501 crore.

It takes the total contract value to Rs 4,318 crore from Rs 3,817 crore for supplies before August 2023.

At 0922 hours, BEML was quoting at Rs 663.70, up Rs 8.30, or 1.27 percent on the BSE.

More Information Visit

                    ⇩
For Quick Trial – 91091 93302
or mail us here:  info@moneyplantresearch.com


Stock market opening bell



top 10 advisory firms in indore


For Quick Trial – 91091-93302 ✔
or mail us here: info@moneyplantresearch.com
or visit https://www.moneyplantresearch.com

Friday, November 20, 2020

Gold price today: Yellow metal holds steady, use dips to buy above Rs 49,800


Gold was trading flat in but above the important Rs 50,000 per 10 gm mark in the Indian markets on November 20, tracking a muted trend in international spot prices.

On the Multi-Commodity Exchange (MCX), December gold contracts were trading higher by 0.10 percent at Rs 50,040 per 10 gram at 0920 hours. December silver futures were trading 0.4 percent higher at Rs 61,757 per kg. Experts are of the view that investors can look to buy the dips towards Rs 49,800.

Gold and silver plunged on November 19 amid hopes of COVID-19 vaccine, strength in the dollar index and upbeat US housing data. December gold futures contract settled at $1864.50 per troy ounce and silver contract settled at $24.10 per troy ounce.

Both precious metals settled on a weaker note in the domestic market as well. December gold settled at Rs 49,992 per 10 gram while silver futures settled at Rs 61,510 per kilogram.

The dollar index climbed again and crossed the 92.50-mark. Upbeat US housing data also pushed both the precious metals lower, experts said.

“We expect gold to hold the crucial support of $1,840 per troy ounce and silver is expected to hold key support levels of $23.70 per troy ounce on a closing basis in the Comex division. At MCX, gold has support at 49,800-49,660 and resistance at 50,200-50,400 levels,” he said.

Jain favoured buying the dip in the gold at around 49,800 with a strict stop loss of Rs 49,550 for the target of 50,200. Silver can be bought at around Rs 61,000 with a strict stop loss of Rs 60,500 and a target of Rs 61,200.


More Information Visit

                    ⇩
For Quick Trial – 91091 93302
or mail us here:  info@moneyplantresearch.com


Wednesday, November 18, 2020

Gold inches lower as COVID-19 vaccine optimism weighs on appeal


Gold prices edged lower on Wednesday due to optimism over a potential COVID-19 vaccine, but concerns over the economic impact from the resurgence of coronavirus cases in the United States limited their decline.

Spot gold fell 0.1% to $1,877.39 per ounce by 0344 GMT, while U.S. gold futures were down 0.5% at $1,875.30.

Gold shed as much as 1.3% on Monday after Moderna said its vaccine was 94.5% effective in preventing COVID-19 in a late-stage trial.

"There is a lack of catalyst for gold prices to rally ... Weighing on prices is a slight depressing of inflation expectations because it's quite clear now that the U.S. fiscal stimulus will probably not be as sizeable as previously imagined," said IG Markets analyst Kyle Rodda.

The emphasis is now on the Federal Reserve to support the U.S. economy through the surge in coronavirus, he added.

Fed chair Jerome Powell said on Tuesday there is "a long way to go" for the economy to recover and that the central bank is committed to using all its tools to support the recovery for as long as required.

Highlighting the grim affect of the pandemic, data showed U.S. retail sales rose less than expected in October and could slow down further amid declining household income as millions of unemployed Americans lose government financial support.

Gold, considered a hedge against inflation and currency debasement, has gained over 24% this year, mainly benefiting from massive global stimulus.

More Information Visit

                    ⇩
For Quick Trial – 91091 93302
or mail us here:  info@moneyplantresearch.com


Stock market opening bell



top 10 advisory firms in indore


For Quick Trial – 91091-93302 ✔
or mail us here: info@moneyplantresearch.com
or visit https://www.moneyplantresearch.com

Tuesday, November 10, 2020

Gland Pharma IPO subscribed 8.6% on 2nd day of bidding, retail portion 12%


The maiden public issue of Gland Pharma, which is owned by Chinese Fosun Pharma, has seen tepid response so far on November 10, the second day of bidding.

The Rs 6,480 crore public offer has been subscribed 8.6 percent as it received bids for 26.93 lakh equity shares against the IPO size of 3.02 crore equity shares, the data available on the exchanges showed.

The IPO size of 3.02 crore shares excluded anchor portion through which the company already raised Rs 1,944 crore on last Friday.

The portion set aside for retail investors has seen 11.8 percent subscription and that of non-institutional investors 1 percent, while the reserved portion of qualified institutional investors has subscribed 10 percent.

Gland Pharma launched public issue on November 9 with a price band of Rs 1,490-1,500 per share, consisting a fresh issue of Rs 1,250 crore and an offer for sale of over 3.48 crore equity shares by the promoter and selling shareholders.

"With benefits of being an out and out integrated injectable/ophthal manufacturer and B2B functionary combined, Gland offers a compelling proposition with its unblemished regulatory track record and customer stickiness besides long-standing manufacturing pedigree, justifying premium valuation," said ICICI Direct which has a subscribe recommendation on the stock.

More Information Visit

                    ⇩
For Quick Trial – 91091 93302
or mail us here:  info@moneyplantresearch.com



Thursday, November 5, 2020

SRF share price hits 52-week high as consolidated net profit rises 57%

 


SRF share price jumped over 6 percent intraday on November 5 after the company reported its September quarter results.

Chemicals maker SRF on November 4 said its consolidated net profit rose 57 percent to Rs 316 crore for the quarter ended September. Its net profit stood at Rs 201 crore in the year-ago period.

"The consolidated revenue of the company increased 21 percent from Rs 1,738 crore to Rs 2,101 crore in Q2FY21 when compared with corresponding period last year," SRF said in a statement.

The stock was trading at Rs 311.30, or 7.01 percent. It has touched a 52-week high of Rs 4,768.40.

The scrip also witnessed spurt in volume by more than 2.80 times and was trading with volumes of 11,053 shares, compared to its five day average of 4,981 shares, an increase of 121.89 percent.

According to Moneycontrol SWOT Analysis powered by Trendlyne, the stock is showing strong momentum - price above short, medium and long term moving averages. The company has zero promoter pledge with the company showing strong cash generating ability from core business - improving cash flow from operation for last 2 years.

More Information Visit

                    ⇩
For Quick Trial – 91091 93302
or mail us here:  info@moneyplantresearch.com



Stock market opening bell



top 10 advisory firms in indore


For Quick Trial – 91091-93302 ✔
or mail us here: info@moneyplantresearch.com
or visit https://www.moneyplantresearch.com

Tuesday, November 3, 2020

Yellow metal trades lower, crucial support placed at Rs 50,800



Gold was trading lower in Indian markets on November 3, tracking a muted trend in the international spot prices. On the Multi-Commodity Exchange (MCX), December gold contracts were trading lower by 0.23 percent at Rs 50,950 per 10 gram at 0920 hours. December silver futures were trading 0.2 percent lower at Rs 61,881 per kg.

Experts are of the view that both gold and silver are likely to remain volatile but yellow metal should find support near Rs 50,800.

The metals gained the previous day amid uncertainty over the US elections outcome and a spike in coronavirus cases in the United States and Europe. Both the precious metals settled on a positive note.

December gold futures contract settled at $1892.50 per troy ounce with a gain of 0.73 percent and silver futures contract settled at $24.03 per troy ounce with a gain of 1.35 percent.

Domestic markets also settled on a positive note. December gold futures contract settled at Rs 51,067 per 10 gram while silver contract settled at Rs 62,007 a kilogram.

“Silver has support at $23.70-23.40 per troy ounce and resistance at $24.40-24.80. On MCX, gold has support at Rs 50,800-50,660 and resistance at Rs 51,300-51,500 levels. Silver has support at Rs 61,400-60,800 levels and resistance at 62800-63500 levels. We suggest buying on dips in both the precious metals,” he said.


More Information Visit

                    ⇩
For Quick Trial – 91091 93302
or mail us here:  info@moneyplantresearch.com


Stock market opening bell



top 10 advisory firms in indore


For Quick Trial – 91091-93302 ✔
or mail us here: info@moneyplantresearch.com
or visit https://www.moneyplantresearch.com

Stock market opening bell

top 10 advisory firms in indore stock advisory in indore For Quick Trial –  91091-93302  ✔ or mail us here:   info@moneyplantresearch.com or...